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Abstract 
Asthma prevalence is increasing and the economic loss due to lack of asthma control is €72 billion in EU 28. Pharmacists have 
a role to play, and a bespoke novel pharmacist-led intervention for asthma patients, called Italian Medicines Use Review (I-
MUR), has shown both effectiveness and cost-effectiveness. The I-MUR intervention enables asthma patients to optimise the 
effect of their medications.  This study aimed at assessing the mismatch between patients’ attitude-perception towards their 
medications and their complaints during the I-MUR service provision. The I-MUR was provided in four different Italian 
locations; data were collected and analysed using descriptive statistics, optimal scaling and contingency tables. The number 
of pharmacists and asthma patients involved in the study was 74 and 895 respectively. The majority of patients (72%) did not 
believe that they had problems with their medications, 78% confirmed that they had full knowledge and understanding of their 
medications, 75% said that their medications were working and 45% confirmed that they missed a dose. The number of patients 
who raised complaints was 683 (76%) and the number of complaints raised by each patient ranged from 1 to 5. Only 18% of 
the patient population reported having neither medicine-related problems nor asthma-related complaints. The use of optimal 
scaling and contingency tables unveiled the mismatch between patients’ attitude-perception towards their medicines and the 
type and number of complaints raised by them during the I-MUR service provision. 
Keywords: optimal scaling, contingency tables, asthma, patients, attitude, perception, complaints, Italian Medicines Use 
Review, community pharmacy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
What is asthma? 
Asthma is a very old word. In modern medical texts, the word "asthma" first originated from the Greek word 
derived from the verb Aazein (breath hard), meaning to exhale with an open mouth or to pant (Asthma History – 
Through The Ages). Homer mentioned it in some of his books (Iliad and Odyssey). Originally, asthma did not 
mean wheeze, but rather noisy breathing, making a blowing nose, panting or even groaning.  
Asthma is a chronic pulmonary inflammatory disease that can result in the narrowing of the airways and reversible 
airflow obstruction when triggered by a variety of stimuli. The narrowing of the airways in the lungs can be caused 
by one, or a combination, of the following changes (GINA, 2015) [1]: 
 
 swelling of the airways; 
 tightening of the muscles surrounding the airways (known as bronchoconstriction); 
 production of excess mucus, which can obstruct the airways; and 
 long-term damage to the walls of the airways, which prevents them from opening as widely as normal.  
 
Epidemiology and economic burden of asthma 
The prevalence of asthma has been increasing since the late 1990’s and it has been estimated that about 400 
million people will suffer from asthma by 2025 [2, 3]. Currently, the number of disability-adjusted life years 
(DALYs) loss to lack of control of asthma worldwide translates into a global loss of 15 million DALYs per year 
and an estimated one in every 250 deaths worldwide is caused by asthma. Asthma accounts for an economic loss 
of €72 billion annually in the 28 countries of the EU [4]; this includes the annual costs of health care (about €20 
billion), the loss of productivity for patients (€14 billion), and a monetised value of DALYs loss of €38 billion. 
 
Role of pharmacists in asthma management 
Many studies have been published showing the role of pharmacists in asthma management.[5-20] A recent 
systematic review and meta-analysis of randomised controlled trials of medication review (pharmacist-led 
consultation) suggested that an isolated medication review has minimal effect on clinical outcomes, no effect on 
quality of life, and lacks evidence of economic outcomes; although studies have shown a decrease in the number 
of drug-related problems, more changes in medication, more drugs with dosage decrease and a greater decrease 
or smaller increase of the number of drugs used. [21] 
A recent publication [22] has demonstrated that a novel bespoke pharmacist-led intervention for asthma patients 
provided effectiveness and cost-effectiveness; this intervention is called Italian Medicines Use review (I-MUR). 
This novel intervention is a face to face consultation provided by community pharmacists to asthma patients. The 
I-MUR consisted of a systematic, structured interview with 22 closed answer questions, conducted in a private 
room within the pharmacy, which covered asthma symptoms, medicines used, attitudes towards medicines and 
adherence. 
 
Amongst the key success factors of I-MUR, there are some questions tailored to reveal the possible mismatch 
between patients’ attitude and perception about their medicines and their complaints about asthma symptoms, if 
any. 
These types of information were extremely important because they prompted the pharmacists not only to be pro-
active but also to make the best and most appropriate recommendations during the consultation. This was deemed 
to be a crucial factor in the success of this pharmacist-led intervention. 
 
 
2. Aim 
This paper aimed at assessing the mismatch between patients’ attitude and perception towards their medications 
and their complaints during the I-MUR service provision, using optimal scaling and contingency tables. 
 
 
3. Method 
The development of I-MUR was guided by the Medical Research (MRC) Framework for the development of 
complex interventions, and retrospectively mapped to it. The justification of this approach relies on the fact that 
I-MUR is a complex intervention. 
Full details of the I-MUR development process, data gathering during the study, inclusion, exclusion criteria, 
patient recruitment, I-MUR provision and data collection have been published elsewhere [23].  
 
Data analysis 
Data were analysed using descriptive statistics, contingency tables (cross-tabulation) for categorical data; 
Goodman and Kruskal’s gamma was used for non-parametric data when they had many tied ranks. The questions 
relative to patients’ attitude and perceptions were analysed using an optimal scaling technique called 
correspondence analysis. 
 
Optimal scaling 
Meulman (1998) in her SPSS white paper entitled “Optimal scaling methods for multivariate categorical data 
analysis” suggested that the aim of the optimal scaling procedure is to turn qualitative variables into quantitative 
one. This aspect is extremely important in particular for researchers working in social and behavioural science, 
because they are often required to use data, which are non-numerical, where the recorded measurements are 
recorded on a scale and therefore have an uncertain unit of measurement. [24] Categories procedures use optimal 
scaling to analyse data that are difficult or impossible for standard statistical procedures to analyse. These 
procedures and their implementation were developed for IBM SPSS Statistics by the Data Theory Scaling System 
Group (DTSS), consisting of members of the Department of Education and Psychology, Faculty of social 
Behavioural Science at Leiden University in the Netherland. The approach adopted by optimal scaling is to assign 
numerical quantification to the categories of each variable, thus allowing standard procedures to be used to obtain 
a solution on the quantified variable. [25] 
The optimal scaling procedure used for our analysis was correspondence analysis because it was recognised as 
the best statistical approach in our case. 
 
Correspondence analysis 
Correspondence analysis (CA) was applied to explore the correlation between two sets of variables (contingency 
table) producing a visual map which highlighted the correspondence between rows and columns. CA can suggest 
unexpected dimensions and relationships between categorical data, and the results can be seen analytically and 
visually.[26]  
The CA methodology was initially proposed by Hirschfeld in 1935, [27] it was further developed in France in 
1973 by Benzécri et al. [28]; then Greenacre introduced the “Theory and Applications of Correspondence 
Analysis” in 1984. [29] 
The principle of CA is conceptually similar to principal component (PC) analysis, but CA is applied to categorical 
data, while PC is applied to continuous data. It is possible to use CA for the analysis of cases-by-variables 
categories matrices for non-negative data. CA is also a multivariate descriptive data analytic technique. As already 
mentioned, the results and information provided by CA are very similar to the ones provided by PC and factor 
analysis (FA).[30] The graphical representation provided by CA shows the relationships between column and row 
categories simplifying complex data and providing detailed descriptions of nearly every single piece of 
information encapsulated in the data set, yielding a simple but exhaustive analysis.[31-32] 
 
 
4. Results 
The number of pharmacists who completed the study providing the I-MUR service was 74, the number of patients 
who received the service was 895. The pharmacists were deliberately divided between the four Italian locations, 
Brescia, Pistoia, Torino, and Treviso.  
 
Patients’ demographic data 
Patients were unevenly split by gender, 45.13% (n=404) were male and 54.86% (n=491) female, their ages are 
shown in Table 1 and the distribution across the four Italian counties in Figure 1. 
 
 
 
 
 
 
 
 
 
 
Table 1 Age range of patients receiving I-MURs  
 
Patients' age N % 
Between 18 and 30 years old 87 9.70 
Between 31 and 40 years old 83 9.30 
Between 41 and 50 years old 128 14.30 
Between 51 and 60 years old 146 16.30 
Between 61 and 70 years old 185 20.70 
Between 71 and 80 years old 185 20.70 
Over 81 years old 78 8.70 
Total 892 99.70 
Missing data 3 0.30 
Total 895   
 
  
 
 
 
Figure 1 Patients’ distribution according to gender and county  
 
 
 
Patient attitudes towards their medications and adherence to treatment 
The majority of patients confirmed they did not believe they had problems with their medications 72.20% (n=640), 
while only 25.60% (n=227) indicated they did have some problems and 2.10% (n=19) believed they had lots of 
problems. Hence there were 27.80% (n=246) patients with self-reported problems. The vast majority of patients 
77.80% (n=689) confirmed that they had full knowledge and understanding of their medicines, 21.10% (n=187) 
only partially and 1.10% (n=10) did not know how to take their medications. In order to visualise the relations 
between these two sets of responses, correspondence analysis was used. 
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Figure 2 Matching problems with knowledge and understanding 
 
 
 
 
 
Figure 2 gives a clear representation of the relationship that was found between patients’ knowledge and how they 
get on with their medication: Dimension 2 (D2) is related to patients’ knowledge and understanding of their 
medications and dimension 1 (D1) is showing whether or not patients report having problems with their 
medications. It appears clear that patients who have a full understanding of their medication do not have problems; 
patients who have only partial knowledge of their medications have some problems, meanwhile the ones who do 
not know much about their medication have lots of problems. The dotted red line represents a division of the 
figure into two parts: left-hand side and right-hand side. The left-hand side of D1 represents patients who did not 
have problems, they confirmed that they knew and understood their medication fully (>70%) meanwhile the right-
hand side represents the percentage (<30%) of patients who were having some/lots of problems and confirmed 
either knowing their medicines only partially or not knowing at all. A positive linear correlation was found 
between these variables (γ = 0.649, p < 0.01).  
 
 
 
 
 
 
 
 
 
 
 
 
A similar analysis between believing medicines are working and expected efficacy was conducted. The proportion 
of patients (n=882) who thought that all their medicines were working was 74.70% (n=659), 20.40% (n=180) 
confirmed that some are working, 0.70% (n=6) none are working and 4.20% (n=37) did not know. The proportion 
(n=882) who thought their medicines were as effective as he/she was expecting were 75.60% (n=667), the ones 
who did not 14.70% (n=130) and 9.60% (n=85) did not know.  
 
 
 
Figure 3 Patterns between patients’ expectation and are medicines working  
 
 
 
 
 
Figure 3 represents patients’ perceptions about their medications. D1 explains, from left to right, the way in which 
patients perceive how their medicines were working, and this value decrease moving from the left side to the right 
side of the X-axis. D2 shows if patients believe that their medications were effective as they were expecting. D2 
is not clearly interpreted as D1. The statement “No, none are working” stands alone and only five patients chose 
this option. Patients who have chosen “yes some are working” is placed between the other two statements “doesn’t 
know and “No”. In this figure, the red circle shows patients who confirm that all the medicines they used were 
working according to their expectation. A strong positive linear correlation was found between the two questions 
(γ = 0.88, p < 0.01).  
 
 
Patients’ self-reported adherence to asthma medications 
Adherence to treatment was assessed using two questions. Of the 895 cases, the question: “Does the patient miss 
any doses of his/her medicines or change when he/she takes them?” was completed in 882 cases. Of these, 44.58% 
(n=399) patients confirmed that they miss a dose or change when they take their medications, 51.40% (n=453) 
did not and 3.40% (n=30) did not know. In the entire sample population, 50.50% (n=202) of male patients were 
potentially non-adherent to treatments compared to 40.90% (n=197) of females. The last time the patient missed 
a dose was reported for 623 cases. This showed that 54.50% (339) patients did not remember when was the last 
time they missed a dose, 12.40% (n=77) last week, 11.90% (n= 74) this week and last month, 9.30% (n=58) 
yesterday. 
 
 
 
Problems and complaints 
After the initial question about problems with medicines, the I-MUR template included a list of specific 
complaints relating to asthma, about which patients were asked. The responses are summarized in Table 2. 
 
 
Table 2  Self-reported complaints identified by patients during I-MUR interviews 
Complaints N % of incidence of 
each complaint   
Daytime symptoms such as shortness of 
breath, tightness in the chest, coughing, 
wheezing, or exacerbations 
470 35.91 
Limitation on activity, including exercise 357 27.27 
Need for rescue medication 237 18.11 
Night time awakening 180 13.75 
Other 65 4.97 
Total number of complaints 1309 
 
 
 
The number of patients who indicated they had one or more complaints was 683 (76.3%). The total number of 
different complaints identified by patients was 1309 (Table 2) with a mean of 1.9 per patient; patients could select 
multiple options, therefore, the percentages do not sum to 100%. Complaints related to daytime symptoms were 
most frequently identified by 470 (35.91%); 9.5% (65) were classified as others such as hands shaking, muscle 
pain, heat, dizziness, tachycardia, fatigue.  Positive correlations were found between age and number of 
complaints (ρ= 0.12, p<0.001), number of active ingredients and number of complaints (ρ =0.25, p<0.01) 
 
 
Table 3 Number of complaints made by patients 
No of complaints No of patients % 
1 289 42.31 
2 218 31.92 
3 122 17.86 
4 50 7.32 
5 4 0.59 
Total 683  
 
 
 
 
 
 
 
A cross-tabulation of the two questions was conducted to find out if patients who did not indicate any problems 
with medicines subsequently confirmed not having asthma-related complaints when specific questioning was 
used (Table 4). 
 
 
Table 4 Cross-tabulation of multiple response sets: Complaints versus problems  
Does the patient complain…… 
             Problems  
Total 
  
  
(no problems) 
  
(some/lots) 
Daytime symptoms such as 
shortness of breath, tightness in the 
chest, coughing, wheezing, or 
exacerbations 
 291 175 466 
Night time awakening  105 74 179 
Need for rescue medication  141 96 237 
Limitation on activity, including 
exercise 
 217 137 354 
No complaints  144 10 154 
Total  575 232 807 
 
Comparison of responses to these two questions indicated that 10 patients out of the 807 (90.2%=802/895) who 
replied to both questions had no complaints but did have medicine-related problems. However, of the 575 who 
indicated that they did not have medicine-related problems, only 144 (25.04%) also had no asthma-related 
complaints. Overall only 144 (17.84% =144/807) patients reported having neither medicine-related problems nor 
asthma-related complaints.  
 
5. Conclusions 
The use of correspondence analysis enabled the visualisation of patients’ attitude towards their medication 
indicating that the vast majority of patients were happy with their medications. Nevertheless, different results 
were highlighted by tables showing patients’ complaints. The results are showing a clear mismatch between 
patients’ attitude and perception and the reality. In fact, data gathered during the I-MUR service showed that of 
575 patients who initially indicated they did not have any medicine-related problems, the majority, in fact, had at 
least one asthma-related complaint.  
The combination of CA and cross-tabulation allowed acquiring a clear picture regarding the mismatch between 
patients’ attitude-perception and the type and number of complaints raised by the patients. 
 
This project is the first project ever conducted in Italian community pharmacy testing whether pharmacists were 
able to undertake the process of completing an I-MUR with asthma patients and uploading the data onto the 
platform. The results have shown one of the first application of CA to analyse the results obtained during a 
pharmacist-led intervention. These results need to be confirmed by a larger study. 
 
 
This analysis provided a clear insight into patients’ attitude-perception and the mismatch between these two 
domains and the type and numbers of complaints raised by the patients as well. This mismatch prompted the 
pharmacist to act pro-actively making suggestions and recommendations to asthma patients. [22]  
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